tirzepatide and spironolactone 3 Interactions: What To Avoid When You're Taking Tirzepatide (2026) 🧠Let's break the drug tirzepatide

A good GLP-1 provider will ask about your full medical history not just your current medications, but things like eating disorder history and when you last had a medical evaluation

These growth factors contribute to cellular repair and growth in the skin, which can go a long way to reversing sun damage and blemishes

Extrapolated to the national adult population, that equates to about three million people

With the Noom Microdose GLP-1 Rx Program, she had access to a full toolkit designed to support lasting change: Personalized daily lessons Food and activity tracking Easy photo-based food logging Muscle Defense workouts to help her protect her muscle mass One-on-one coaching and community support Clinician access whenever she needed guidance GLP-1 Companion tools to monitor and manage side effects Together, the microdose GLP-1 medication and Nooms behavior-change guidance gave her the support she had been missing

Common gastrointestinal side effects include nausea, vomiting, diarrhoea, and constipation, which occur in a significant proportion of patients, particularly during dose escalation

Side Effects and Safety: Similarities, Differences, and Red Flags Common Side Effects (Both) Typical side effects listed in labeling include: Nausea Vomiting Diarrhea or constipation Abdominal pain or discomfort Decreased appetite Practical tolerability tips many clinicians use (individualize to your care plan): Eat smaller meals and stop when comfortably full Prioritize protein and fiber Avoid large, high-fat meals during dose escalation Hydrate consistently, especially if nausea limits intake Boxed Warning and Key Contraindications (Both) Both products carry a boxed warning related to thyroid C-cell tumors in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)